An van Es-Johansson
CIK: 0001795902
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Oct 1, 2026CNSY
CERENOME, INC.
Exercise(M)Direct921 shares- - Jul 1, 2026PSTV
PLUS THERAPEUTICS, INC.
Exercise(M)Direct922 shares- - May 14, 2026PSTV
PLUS THERAPEUTICS, INC.
Award(A)DirectStock Option (Right to Buy)
3.7K shares- - May 14, 2026PSTV
PLUS THERAPEUTICS, INC.
Award(A)DirectRestricted Stock Units
3.7K shares- - Dec 9, 2025SVRA
Savara Inc
Award(A)Direct40K shares- - Aug 13, 2025PSTV
PLUS THERAPEUTICS, INC.
Award(A)DirectStock Option (Right to Buy)
297.8K shares- - Feb 18, 2025PSTV
PLUS THERAPEUTICS, INC.
Award(A)DirectStock Option (Right to Buy)
40.1K shares- - Dec 12, 2024SVRA
Savara Inc
Award(A)Direct40K shares- - Dec 12, 2024(LUMO)
LUMOS PHARMA, INC.
Disposition(D)Direct1.1K shares- - Sep 11, 2024PSTV
PLUS THERAPEUTICS, INC.
Award(A)DirectStock Option (Right to Buy)
3.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 |  CNSY CERENOME, INC. | Exercise(M) | 921 | - | $0 | Direct |
| Jul 1, 2026 |  PSTV PLUS THERAPEUTICS, INC. | Exercise(M) | 922 | - | $0 | Direct |
| May 14, 2026 | PSTV PLUS THERAPEUTICS, INC. | Award(A) Stock Option (Right to Buy) | 3,686 | - | - | Direct |
| May 14, 2026 | PSTV PLUS THERAPEUTICS, INC. | Award(A) Restricted Stock Units | 3,686 | - | - | Direct |
| Dec 9, 2025 |  SVRA Savara Inc | Award(A) | 40,000 | - | - | Direct |
| Aug 13, 2025 | PSTV PLUS THERAPEUTICS, INC. | Award(A) Stock Option (Right to Buy) | 297,794 | - | - | Direct |
| Feb 18, 2025 | PSTV PLUS THERAPEUTICS, INC. | Award(A) Stock Option (Right to Buy) | 40,122 | - | - | Direct |
| Dec 12, 2024 | SVRA Savara Inc | Award(A) | 40,000 | - | $0 | Direct |
| Dec 12, 2024 | /logo?size=32) (LUMO) LUMOS PHARMA, INC. | Disposition(D) | 1,100 | - | $0 | Direct |
| Sep 11, 2024 | PSTV PLUS THERAPEUTICS, INC. | Award(A) Stock Option (Right to Buy) | 3,650 | - | - | Direct |
1-10 of 10 transactions
About van Es-Johansson An
van Es-Johansson An (SEC CIK 0001795902) files insider reports with the SEC as Director of CERENOME, INC. (CNSY), Director of Savara Inc (SVRA) and Director of LUMOS PHARMA, INC. ((LUMO)).
Signal8 holds 9 ownership filings by van Es-Johansson An, all Form 4s, filed between Sep 12, 2024 and Oct 1, 2026. Those filings report 10 transactions, from Sep 11, 2024 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on van Es-Johansson An's filings is in HOUSTON, TX.
Recent filings by van Es-Johansson An
- Oct 1, 2026: Option exercise of CNSY shares (Form 4, code M).
- Jul 1, 2026: Option exercise of PSTV shares (Form 4, code M).
- May 14, 2026: Grants or awards of PSTV derivative securities (2 lines, Form 4, code A).
- Dec 9, 2025: Grant or award of SVRA shares (Form 4, code A).
- Aug 13, 2025: Grant or award of PSTV derivative securities (Form 4, code A).
Other insiders filing for CERENOME, INC. (CNSY)
- Hawkins Richard J, Director
- Clowes Howard, Director
- Sims Andrew John Hugh MacIntyre, Chief Financial Officer
- HEDRICK MARC H, Chief Executive Officer
- ANDREWS RONALD ASBURY, Director
- Guse Kyle, Director